Paper42272829
Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review.
Teng Y and 3 others. Front Pharmacol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review. Papers, record 42272829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42272829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33935784 | Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33935784 | PubMed |
| 2 | 34788653 | A meta-analysis of randomized controlled trials on therapeutic efficacy and safety of autologous cell therapy for atherosclerosis obliterans. | J Vasc Surg | 2022 | https://conductscience.org/library/papers/34788653 | PubMed |
| 3 | 8638868 | Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease. | Angiology | 1996 | https://conductscience.org/library/papers/8638868 | PubMed |
| 4 | 12243231 | Anticoagulant activities in salivary glands of tabanid flies. | Med Vet Entomol | 2002 | https://conductscience.org/library/papers/12243231 | PubMed |
| 5 | 35700853 | Scoping review of the medicinal effects of Eupolyphaga sinensis Walker and the underlying mechanisms. | J Ethnopharmacol | 2022 | https://conductscience.org/library/papers/35700853 | PubMed |
| 6 | 22218934 | Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. | Genes Nutr | 2012 | https://conductscience.org/library/papers/22218934 | PubMed |
| 7 | 39701744 | [Clinical comprehensive evaluation of Jiangzhi Tongluo Soft Capsules for treating hyperlipidemia (syndrome of blood stasis and Qi stagnation)]. | Zhongguo Zhong Yao Za Zhi | 2024 | https://conductscience.org/library/papers/39701744 | PubMed |
| 8 | 38694094 | Protective effects of the bioactive peptide from maggots against skin flap ischemia‒reperfusion injury in rats. | Heliyon | 2024 | https://conductscience.org/library/papers/38694094 | PubMed |
| 9 | 30759852 | Apricot Kernel Extract and Amygdalin Inhibit Urban Particulate Matter-Induced Keratoconjunctivitis Sicca. | Molecules | 2019 | https://conductscience.org/library/papers/30759852 | PubMed |
| 10 | 34502424 | The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb-A Summary Update. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502424 | PubMed |
| 11 | 38931317 | The Effects of Almond Consumption on Cardiovascular Health and Gut Microbiome: A Comprehensive Review. | Nutrients | 2024 | https://conductscience.org/library/papers/38931317 | PubMed |
| 12 | 32924559 | Traditional Chinese Medicine Could Play an Important Role in Integrative Palliative Care in China. | J Altern Complement Med | 2020 | https://conductscience.org/library/papers/32924559 | PubMed |
| 13 | 39528464 | Inflammation in atherosclerosis: pathophysiology and mechanisms. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39528464 | PubMed |
| 14 | 29952767 | Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29952767 | PubMed |
| 15 | 39355399 | Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review. | J Lipid Atheroscler | 2024 | https://conductscience.org/library/papers/39355399 | PubMed |
| 16 | 29950086 | [Species and medical history of "Xishuang" medicinal materials]. | Zhongguo Zhong Yao Za Zhi | 2018 | https://conductscience.org/library/papers/29950086 | PubMed |
| 17 | 32692190 | Herbal therapy treatment in thromboangiitis obliterans: a retrospective clinical study. | Ann Palliat Med | 2020 | https://conductscience.org/library/papers/32692190 | PubMed |
| 18 | 37381959 | [Effect and mechanism of Dahuang Zhechong Pills in improving liver aging in rats by regulating ROS-mediated PI3K/Akt/FoxO4 signaling pathway]. | Zhongguo Zhong Yao Za Zhi | 2023 | https://conductscience.org/library/papers/37381959 | PubMed |
| 19 | 40666694 | Exploring the Complementary Role of Traditional Chinese Medicine in Enhancing Percutaneous Coronary Intervention Outcomes: Mechanisms, Benefits, and Future Research Directions. | Ther Clin Risk Manag | 2025 | https://conductscience.org/library/papers/40666694 | PubMed |
| 20 | 38888716 | Dahuang Zhechong Pill Alleviates Liver Fibrosis Progression by Regulating p38 MAPK/NF-κ B/TGF-β1 Pathway. | Chin J Integr Med | 2024 | https://conductscience.org/library/papers/38888716 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42272829
GET https://conductscience.org/api/papers/v1/42272829/references?page=2